KATHERINE LEDFORD: Open Payments
NPI 1386233997 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 20 payments from 10 companies in 2025. Trend: 2023 $715 · 2024 $949 · 2025 $583
Food & beverage: $516Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $177 |
| Janssen Biotech, Inc. | 5 | $135 |
| LEO Pharma Inc. | 2 | $119 |
| Incyte Corporation | 2 | $46 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Organon LLC | 2 | $6 |
Products named: TREMFYA, RINVOQ, ANZUPGO, SKYRIZI, OPZELURA, Zoryve, ADBRY, DYSPORT.
Industry payments across ID — which companies pay providers there.
